Shingles (Herpes Zoster) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles
Condition: Herpes Zoster Interventions: Biological: Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A); Drug: Placebo Sponsor: GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials
Long-term Immunogenicity of a Live Attenuated Herpes Zoster Vaccine in SLE Patients
Condition: Lupus Erythematosus Intervention: Diagnostic Test: Immunogenicity Sponsors: Tuen Mun Hospital; The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials
Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients
Condition: Lupus Erythematosus Intervention: Diagnostic Test: Immunogenicity Sponsors: Tuen Mun Hospital; The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials
